Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn Asiafocus Regulatory News (AAS)

Share Price Information for Abrdn Asiafocus (AAS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 279.00
Bid: 278.00
Ask: 280.00
Change: 4.00 (1.45%)
Spread: 2.00 (0.719%)
Open: 279.00
High: 279.00
Low: 279.00
Prev. Close: 275.00
AAS Live PriceLast checked at -
abrdn Asia Focus is an Investment Trust

To maximise long-term total return from a portfolio made up predominantly of smaller quoted companies (with a market cap of up to approximately USD 1.5bn at the time of investment) in the economies of Asia and Australasia, ex Japan.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Long Term Fixed Rate Borrowing

20 Oct 2020 15:56

RNS Number : 6906C
Aberdeen Standard Asia Focus PLC
20 October 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION (INCLUDING THE UNITED STATES) WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

 

20 October 2020

 

 

ABERDEEN STANDARD ASIA FOCUS PLC ("the Company")

 

Legal Entity Identifier (LEI): 5493000FBZP1J92OQY70

 

New long-term fixed rate borrowing

 

 

The Board of Aberdeen Standard Asia Focus PLC (the "Company") today announces that it has agreed terms (through the acceptance of a conditional offer that is subject to diligence and agreement of legal documentation) to extend and secure the Company's long-term borrowings through the issuance of a £30 million 15 year Senior Unsecured Loan Note (the "Loan Note") at an annualised interest rate of 3.05%. The Loan Note will be unsecured, unlisted and denominated in sterling. The Loan Note shall rank pari passu with the Company's other unsecured and unsubordinated financial indebtedness.

 

The Company intends to use the proceeds of the Loan Note to repay, and cancel in full, the Company's £20 million Revolving Credit Facility ("RCF"), of which £11.2million is currently drawn. The remainder will be available for the Company's investment manager, Aberdeen Standard Investments (the "Manager"), to invest on behalf of the Company.

 

An additional £35 million will also be available for drawdown by the Company for a five-year period.

The Board's current intention would be to only draw this down to repay any of the Company's existing Convertible Unsecured Loan Stock, either at their redemption in 2025, or before. This will be kept under review. The minimum drawdown would be in tranches of £10m and the exact terms of such a borrowing would be agreed at the time of drawdown. The Company will pay no fees on this facility, other than minimal legal fees.

 

The Board believes that it is in the long-term interest of the Ordinary shareholders to take advantage of the current low interest rates prevailing in today's market to extend, and secure, the Company's debt profile beyond the CULS redemption date. It will provide the Manager with greater flexibility and additional cash resources to take advantage of investment opportunities that are expected to arise over the coming period.

 

Asia remains the principal engine for growth in the world and one of the most exciting regions for true active investing in smaller companies. Since the Company's inception 25 years ago, the opportunity to uncover tomorrow's leading businesses and to access domestic growth remains as strong as ever. The region's dynamism has accelerated in recent years and, as a result, the Company's portfolio has evolved, with a gradual but very conscious shift in invested capital away from more mature businesses that have proven their success to more nascent opportunities in areas such as technology, healthcare and industrials.

 

Once the initial drawdown is completed (expected to be 1 December 2020) and the RCF has been repaid, the Company's borrowings are expected to total approx. £66.7m, providing an extra approx. £18.7m of cash for investment.

 

The Board considers that the existing low interest rate environment creates an attractive opportunity to secure fixed rate, long-dated financing with the intention of enhancing long-term total returns for shareholders. The Company remains committed to the use of gearing as one of the principal advantages of the Company's investment trust structure.

 

Hugh Young, Aberdeen Standard Investments, said:

 

"Great opportunities exist today in small companies in the Asian region. This rearrangement of the Company's gearing facilities gives us the continued ability to invest for the long-term in this exciting area of the market that will continue to dominate the world's growth most particularly in the post COVID-19 world."

 

Nigel Cayzer, Chairman said:

 

"The change in the structure of the Company's gearing will strengthen the Company's balance sheet and provide greater certainty with regard to its borrowings over an extended period. This will enhance the Manager's ability to invest for the longer term into this exciting region."

 

Contacts

 

Aberdeen Standard Investments

William Hemmings 020 7463 6223

Charles Mearns 0131 528 4132

 

Panmure Gordon 020 7886 2500

Michael Bateman

Oliver Packard

Sapna Shah

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFESISLIFII
Date   Source Headline
3rd May 20244:40 pmRNSQuarterly disclosure
3rd May 202412:54 pmRNSNet Asset Value(s)
2nd May 202412:59 pmRNSNet Asset Value(s)
1st May 202410:45 amRNSTotal Voting Rights
30th Apr 202412:55 pmRNSNet Asset Value(s)
30th Apr 202411:20 amRNSGearing disclosure
29th Apr 202412:38 pmRNSNet Asset Value(s)
26th Apr 20245:23 pmRNSTransaction in Own Shares
26th Apr 202412:45 pmRNSNet Asset Value(s)
25th Apr 20241:27 pmRNSNet Asset Value(s)
24th Apr 20245:41 pmRNSTransaction in Own Shares
24th Apr 20245:07 pmRNSCULS Interest Payment Date
24th Apr 20245:06 pmRNSCULS Conversion Notice
24th Apr 202412:11 pmRNSNet Asset Value(s)
23rd Apr 20245:15 pmRNSTransaction in Own Shares
23rd Apr 202412:47 pmRNSNet Asset Value(s)
22nd Apr 20242:04 pmRNSGearing disclosure
22nd Apr 202412:21 pmRNSNet Asset Value(s)
19th Apr 202412:46 pmRNSNet Asset Value(s)
18th Apr 20245:08 pmRNSTransaction in Own Shares
18th Apr 20243:44 pmRNSHolding(s) in Company
18th Apr 202412:36 pmRNSNet Asset Value(s)
17th Apr 20245:20 pmRNSTransaction in Own Shares
17th Apr 202412:08 pmRNSNet Asset Value(s)
16th Apr 20241:00 pmRNSNet Asset Value(s)
15th Apr 20245:43 pmRNSPortfolio Disclosures
15th Apr 20243:27 pmRNSGearing Disclosures
15th Apr 202412:48 pmRNSNet Asset Value(s)
12th Apr 202412:56 pmRNSNet Asset Value(s)
12th Apr 202412:38 pmRNSDoc re. Half Yearly Report
11th Apr 202412:42 pmRNSNet Asset Value(s)
10th Apr 20245:21 pmRNSTransaction in Own Shares
10th Apr 202412:53 pmRNSNet Asset Value(s)
9th Apr 202411:59 amRNSNet Asset Value(s)
8th Apr 20245:17 pmRNSTransaction in Own Shares
8th Apr 20242:46 pmRNSGearing disclosure
8th Apr 20241:00 pmRNSNet Asset Value(s)
5th Apr 202412:33 pmRNSNet Asset Value(s)
4th Apr 202412:47 pmRNSNet Asset Value(s)
3rd Apr 20244:38 pmRNSHolding(s) in Company
3rd Apr 202412:47 pmRNSNet Asset Value(s)
2nd Apr 20243:33 pmRNSGearing disclosure
2nd Apr 202410:56 amRNSHolding(s) in Company
2nd Apr 202410:17 amRNSTotal Voting Rights
28th Mar 20242:04 pmRNSNet Asset Value(s)
28th Mar 20247:00 amRNSHalf-year Report
27th Mar 20244:04 pmRNSHolding(s) in Company
27th Mar 202412:19 pmRNSNet Asset Value(s)
26th Mar 202412:24 pmRNSNet Asset Value(s)
25th Mar 20243:58 pmRNSGearing disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.